CIXUTUMUMAB
UNII 2285XW22DR

Substance Identification & Data

This profile provides standardized clinical and technical data for Cixutumumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2285XW22DR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 947687-12-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2285XW22DR
CAS Registry Number
947687-12-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CIXUTUMUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9099
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
UU-40
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cixutumumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CIXUTUMUMAB

Common Names & Synonyms

CIXUTUMUMAB [INN]
CIXUTUMUMAB [USAN]
CIXUTUMUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL IMC-A12 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IMC-A12 .GAMMA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL IMC-A12 .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-A12 .GAMMA.-CHAIN, DIMER

Technical Codes

IMC-A12
NSC-742460